Synthesis of 2'-Deoxy-2'-[ 18F]fluoro-9-β- DArabinofuranosylguanine: A novel agent for imaging T-cell activation with PET

Molecular Imaging and Biology

Volumn 13, Issue 5, 2011, Pages 812-818

  Namavari, Mohammad ^a,b,c   Chang, Ya Fang ^a,b,c   Kusler, Brenda ^b   Yaghoubi, Shahriar ^a,b,c   Mitchell, Beverly S ^b   Gambhir, Sanjiv Sam ^a,b,c  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Stanford University   (United States)

Author keywords

9 ( D Arabinofuranosyl) guanine (AraG); Imaging; Positron emission tomography (PET); T cells

Indexed keywords

2'DEOXY 2' FLUORO 9 BETA DEXTRO ARABINOFURANOSYLGUANINE F 18; GUANOSINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL ASSAY; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; FLUORINATION; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; T LYMPHOCYTE ACTIVATION;

ARABINONUCLEOSIDES; CELL LINE, TUMOR; HUMANS; LYMPHOCYTE ACTIVATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; POSITRON-EMISSION TOMOGRAPHY; T-LYMPHOCYTES;

EID: 84855279531     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0414-x     Document Type: Article

References (26)

1. Barrio JR, Namavari M, Phelps ME, Satyamurthy N (1996) Elemental fluorine to 8-fluoropurines in one step. J Am Chem Soc 118:10408-10411 (Pubitemid 26381222)
2. Carson DA, Wasson DB, Esparza LM, Carrera CJ, Kipps T, Cottam HB (1992) Oral antilymphocyte activity and induction of apoptosis by 2- chloro-2'-arabinofluoro-2'-deoxyadenosine. Pro Natl Acad Sci USA 89:2970-2974
3. Takahashi T, Kanazawa J, Akinaga S, Tamoaki T, Okabe M (1999) Cancer antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-Darbionfuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration. Chemother Pharmacol 43:233-240 (Pubitemid 29042492)
4. Kim CG, yang DJ, Kim EE, Cherif A, Kuang LR, Li C, Tansey W, Liu CW, Li SC, Wallace S, Podolof DA (1996) Assesment of tumor cell proliferation using [18F]fluorodeoxyadenosine and [18F]fluorouracile. J Pharm Sci 85:339-344
5. Marquez VE, Tseng CK-H, Mitsuya H, Aoki S, Kelly JA, H-jr F, Roth JS, Broder S, Johns DG, Driscoll JS (1990) Acid stable 2'-fluoro purine dideoxynuceosides as active agents against HIV. J Med Chem 33:978-985 (Pubitemid 20085902)
6. Barchi JJ, Marquez VE, Driscoll JS, H-jr F, Mitsuya H, Shirasaka T, Aoki S, Kelly JA (1991) Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs. J Med Chem 34:1647-1655
7. Masood R, Ahluwalia GS, Cooney DA, Fridland A, Marquez VE, Driscoll JS, Hao Z, Mitauya H, Pemo CF, Broder S, Johns DG (1990) 2'-Flouro-2', 3'-dideoxyarabinosyladenine: A metaboloically stable analogues of antiviral agent 2', 3'- dideoxyarabinosyladenine. Mol Pharmacol 37:590-596
8. Hitchcock MJ, Woods K, DeBoeck H, Ho HT (1990) Biochemical pharmacology of 2-flouro-2', 3'-dideoxyarabinofuranosyladenine, an inhibitor of HIV with improved metabolic and chemical stability over 2', 3'-dideoxyadenosine. Antiviral Chem Chemother 1:319-327
9. Silverman RB (1988) In mechanism-based enzyme inactivation: Chemistry and enzymology, vol 1. CRC, Boca Raton, p 59
10. Mitchell BS, Kelly WN (1980) Purinogenic immunodeficiency diseases: Clinical features and molecular mechanisums. Ann Intern Med 92:826-831 (Pubitemid 10124373)
11. Shewach DS, Mitchell BS (1989) Differential metabolism of 9-bta-Darabinofuranosylguanine in human leukemic cells. Cancer Res 49:6498-6502 (Pubitemid 20008777)
12. Leanza L, Ferraro P, Bianchi V (2008) Metabolic interrelations within guanine deoxynucleotide pools for mitochondrial and nuclear DNA maintenance. J Biol Chem 283:16437-16445
13. Kurtzberg J, Ernst TJ, keating MJ, Gandhi V, Hodge JP, Kisor DF, Lager JJ, Stephens C, Levin J, Kerenitsky T, Elion G, Mitchell BS (2005) Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. J Clin Oncol 23:3396-3403
14. Curbo S, Karlsson A (2006) Nelarabine: A new purine analog in the treatment of hemtologic malignancies. Rev Recent Clin Trials 1:185-192
15. Radu CG, Shu CJ, Nair-Gill E, Shelly MS, Barrio JR, Satyamurthy N, Phelps ME, Witte ON (2008) Molecular imaging of lymphoid organs and immuneactivation by positron emission tomography with a new [18F]labeled 2'-deoxycytidine analog. Nat Med 14:783-788 (Pubitemid 351951515)
16. Lyer M, Barrio JR, Namavari M, Bauer E, Satyamurthy N, Nguyen K, Toyokuni T, Phelps ME, Herschman HR, Gambhir SS (2001) 8-[18F] Fluoropenciclovir: An improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med 42:96-105 (Pubitemid 32104785)
17. Namavari M, Barrio JR, Toyokuni T, Gambhir SS, Cherry SR, Herschman HR, Phelps ME, Satyamurthy N (2000) Synthesis of 8- [18F]fluoroguanine derivatives: In vivo probes for imaging gene expression with PET. Nucl Med Biol 27:157-162 (Pubitemid 30204570)
18. Barrio JR, Namavari M, Phelps ME, Satyamurthy N (1996) Regioselective fluorination of substituted guanines with dilute F2: A facile entry to 8- fluoroguanine derivatives. J Org Chem 61:6084-6085 (Pubitemid 26305477)
19. Alauddin MM, Fissekis JD, Conti PS (2003) Synthesis of [18F]labeled adenosine analogues as potential PET imaging agents. J Label Compd Radiopharm 46:805-814 (Pubitemid 37047669)
20. Pankieweiz KW, Krzeminiski J, Watanabe KA (1992) Synthesis of 2'-ß- fluoro- and 3'-a-fluoro-substituted guanine nucleosides: Effects of sugar conformational shifts on nucleophilic displacement of the 2'-hydroxy and 3'-hydroxy group with DAST. J Org Chem 57:7315-7321 (Pubitemid 23035953)
21. Chatila T, Silverman L, Miller R, Geha R (1989) Mechanism of T cell activation by the calcium ionophore ionomycin. J Immunol 143:1283-1289 (Pubitemid 19211362)
22. Reichman U, Watanabe KA, Fox JJ (1975) A practical synthesis of 2- deoxy-2-fluoro-D-arabinofuranose derivatives. Carbohydr Res 42:233-240
23. Tann CH, Brodfuehrer PR, Brundige SP, C-Jr S, Howell HG (1985) Fluorocarbohydrate in synthesis. An efficient synthesis of 1-(2-Deoxy- 2-fluoro-ß-D-arabinofuranosl)-5-iodouracil (ß-FIAU) and 1-(2-Deoxy-2- fluoro-ß-D-arabinofuranosl)thymine (ß-FMAU). J Org Chem 50:3644-3647 (Pubitemid 16243825)
24. Chu CK, Matulic-Aamic J, Huang JT, Chou TC, Bruchenal JH, Fox JJ, Watanabe KA (1989) Synthesis of 9-(-2-Deoxy-2-fluoro-b-D-arabinofuranosy)- 9-H-purines and their biological activites. Chem Pharm Bull 37:336-339 (Pubitemid 19082569)
25. Alauddin MM, Conti PS, Fissekis JD (2003) General synthesis of 2'- deoxy-2'-[18F]fluoro-1-ß-D-arabinofuranosyluracil and its 5-substituted nucleosides. J Label Radiopharm 46:285-289 (Pubitemid 36514050)
26. Cooper TM (2007) Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Ther Clin Risk Manage 3(6):1135-1141